fbpx

NephCure

For Rare Kidney Disease

Pediatric Patients

LEARN MORE

Adult Patients

LEARN MORE

Health Care Professionals

LEARN MORE

Kidney Disease in Communities of Color

LEARN MORE

We fund research and provide support and education to people affected by rare, protein-spilling kidney diseases.

More than 1 in 7 U.S. adults have chronic kidney disease, but up to 90% are unaware that they are sick. Although protein-spilling kidney diseases are individually rare, together they are a leading cause of kidney failure. When NephCure was formed in 2000, there was little research into Nephrotic Syndrome and few options for patients.

$40M+

NephCure funds invested in research to date.

50+

new potential treatments being tested for patients.

160+

NephCure Specialists nationwide providing expert care.

40k

patients and families reached yearly through our programs.

Patient Stories

LEARN MORE

Travere Therapeutics Announces Results from DUPLEX Study in FSGS

Travere Therapeutics Announces Results from DUPLEX Study in FSGS

Read More
NephCure Joins Enon Tabernacle’s Men’s Health Initiative

NephCure Joins Enon Tabernacle’s Men’s Health Initiative

Read More
NephCure Unveils New Branding

NephCure Unveils New Branding

Read More
dummy-img

NephCure Action Network Members Help Enact Sections of New Era Bill into Law

Read More

Get Involved

Now is a pivotal moment for Nephrotic Syndrome patients. Take action to help shape the future of treatment and care for rare kidney disease.

Advance Research
Join Your Local Community
Donate

Upcoming Events

Sign up for our emails »

150 S Warner Road
Ste 402
King of Prussia, PA 19406
1-866-NephCure (637-4287)
info@nephcure.org
EIN: 38-3569922

© Copyright 2023 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.